Related content

Advanced glycation of apolipoprotein A-I impairs its anti-atherogenic properties

By Hoang A.   Murphy A.   Coughlan M.   Thomas M.   Forbes J.   O’Brien R.   Cooper M.   Chin-Dusting J.   Sviridov D.  

Diabetologia, Vol. 50, Iss. 8, 2007-08 ,pp. : 1770-1779

Springer Publishing Company

Access to resources Recommend Favorite

Atorvastatin and the plasma activities of lipoprotein lipase, hepatic lipase and lecithin:cholesterol acyltransferase in patients with mixed hyperlipidemia

By Heller F.R.   Descamps O.S.   Hondekijn J.C.   Desager J.P.  

European Journal of Internal Medicine, Vol. 11, Iss. 1, 2000-02 ,pp. : 33-38

Elsevier

Access to resources Recommend Favorite

Isolation and preliminary microheterogeneity studies of lecithin-cholesterol acyltransferase in plasma from individual patients infected with Schistosomiasis mansoni

By de Menezes Lima V.L.   Cannizzaro H.M.   Owen J.S.  

International Hepatology Communications, Vol. 6, Iss. 6, 1997-03 ,pp. : 300-305

Elsevier

Access to resources Recommend Favorite

Evolving Functions of Apolipoprotein AIV - cholesterol acyltransferase by human apolipoprotein AIV

By Steinmetz A.   Schneider W.J.  

Trends in Cardiovascular Medicine, Vol. 9, Iss. 6, 1999-08 ,pp. : 153-157

Elsevier

Access to resources Recommend Favorite

The Effects of Altered Apolipoprotein A-I Structure on Plasma HDL Concentration

By Sorci-Thomas M.G.   Thomas M.J.  

Trends in Cardiovascular Medicine, Vol. 12, Iss. 3, 2002-04 ,pp. : 121-128

Elsevier

Access to resources Recommend Favorite